The planned resignation of Marty Makary from the US Food and Drug Administration is creating fresh uncertainty over abortion access across the United States, particularly regarding the future of abortion pills prescribed through telehealth and delivered by mail.
Makary, who faced criticism from anti-abortion groups during his tenure as FDA commissioner, is expected to leave the agency amid growing political pressure from conservative activists and internal tensions within the Trump administration.
The development matters because the FDA now sits at the center of one of the country’s most significant legal and political battles over abortion access. [Read more…] about Why one FDA resignation could affect abortion access across America